News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Vacci-Test Corporation Release: European Approval of VACCI-TEST(TM) Tetanus
June 10, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CALGARY, ALBERTA--(Marketwire - June 10, 2008) - Vacci-Test Corporation ("VTC") of Calgary, Alberta, Canada is pleased to announce that its subsidiary, Vacci-Test Europe, has received the CE mark for its first product, VACCI-TEST™ Tetanus.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Policy
Former CBER Chief Marks Decries New FDA COVID-19 Framework
June 26, 2025
·
3 min read
·
Tristan Manalac
Duchenne muscular dystrophy
FDA Reviews Sarepta’s Elevidys After Second Patient Death
June 25, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open
June 25, 2025
·
2 min read
·
Tristan Manalac
Podcast
FDA Churn Continues, RFK Faces Congress, Obesity Insights at ADA, BIO2025 Recap
June 25, 2025
·
2 min read
·
Heather McKenzie